Amarin Corp Plcuk (AMRN) Assets Average (2011 - 2026)

Amarin Corp Plcuk (AMRN) reported Assets Average of $658.3 million for Q1 2026, down 1.83% year-over-year from $670.5 million in Q1 2025, and down 1.06% quarter-over-quarter from $665.3 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Assets Average (2011 - 2026) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 16 years of Assets Average data on file, last reported at $658.3 million in Q1 2026.

  • Assets Average for Q1 2026 came in at $658.3 million, down 1.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $658.3 million (down 1.83% YoY), and the FY2025 annual result was $678.1 million, down 10.61% from the prior year.
  • Assets Average eased to $658.3 million in Q1 2026 per AMRN's latest filing, from $665.3 million in the prior quarter.
  • Over five years, Assets Average peaked at $1.0 billion in Q1 2022 and troughed at $658.3 million in Q1 2026.
  • A 5-year average of $804.2 million and a median of $810.8 million in 2024 frame the typical range for Assets Average.
  • The sharpest annual moves came in 2022 and 2025: Assets Average advanced 4.37% in 2022, then retreated 17.31% in 2025.
  • A 5-year view of Assets Average shows it stood at $897.2 million in 2022, then fell by 6.9% to $835.4 million in 2023, then dropped by 14.05% to $718.0 million in 2024, then fell by 7.34% to $665.3 million in 2025, then decreased by 1.06% to $658.3 million in 2026.
  • Business Quant data shows AMRN's Assets Average at $658.3 million in Q1 2026, $665.3 million in Q4 2025, and $665.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 83.03 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 114.53 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 200.05 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 135.21 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 132.78 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 91.55 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 57.65 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 208.08 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 88.26 Bn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn 658.27 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 658.27 Mn
Dec 31, 2025 665.29 Mn
Sep 30, 2025 664.97 Mn
Jun 30, 2025 662.91 Mn
Mar 31, 2025 670.52 Mn
Dec 31, 2024 717.98 Mn
Sep 30, 2024 775.26 Mn
Jun 30, 2024 794.96 Mn
Mar 31, 2024 810.85 Mn
Dec 31, 2023 835.36 Mn
Sep 30, 2023 849.52 Mn
Jun 30, 2023 860.10 Mn
Mar 31, 2023 873.18 Mn
Dec 31, 2022 897.24 Mn
Sep 30, 2022 940.77 Mn
Jun 30, 2022 973.47 Mn
Mar 31, 2022 1.02 Bn
Dec 31, 2021 1.05 Bn
Sep 30, 2021 1.04 Bn
Jun 30, 2021 1.02 Bn